Literature DB >> 4006773

Alzheimer's disease. Is it worth treating?

L E Hollister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006773     DOI: 10.2165/00003495-198529060-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  18 in total

1.  Drugs for mental disorders of old age.

Authors:  L E Hollister
Journal:  JAMA       Date:  1975-10-13       Impact factor: 56.272

2.  The investigation of dementia: results in 200 consecutive admissions.

Authors:  J S Smith; L G Kiloh
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

Review 3.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

4.  Vasodilators in senile dementias: a review of the literature.

Authors:  J A Yesavage; J R Tinklenberg; L E Hollister; P A Berger
Journal:  Arch Gen Psychiatry       Date:  1979-02

5.  A trial of Gerovital H-3 in depression during senility.

Authors:  G Sakalis; D Oh; S Gershon; B Shopsin
Journal:  Curr Ther Res Clin Exp       Date:  1974-01

6.  Psychiatric problems of the aged.

Authors:  C W Schmidt
Journal:  J Am Geriatr Soc       Date:  1974-08       Impact factor: 5.562

7.  A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).

Authors:  S D Brinkman; N Pomara; P J Goodnick; N Barnett; E F Domino
Journal:  J Clin Psychopharmacol       Date:  1982-08       Impact factor: 3.153

Review 8.  Chronic brain disease: an overview.

Authors:  C E Wells
Journal:  Am J Psychiatry       Date:  1978-01       Impact factor: 18.112

9.  Senility reconsidered. Treatment possibilities for mental impairment in the elderly. Task force sponsored by the National Institute on Aging.

Authors: 
Journal:  JAMA       Date:  1980-07-18       Impact factor: 56.272

10.  Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

Authors:  K L Davis; R C Mohs
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

View more
  2 in total

Review 1.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.

Authors:  A N Wadworth; P Chrisp
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.